Jim,
The site is probably somewhat biased, however the information is also true.
I see the whole embryonic stem cell issue as a canard. The real issue is MONEY and CONTROL. The adult stem cell research, which does not have the ethical dilemas, has been progressing quite well, though very quietly, in some high profile labs such as MIT and John Hopkins.
All ethical issues aside, the adult stem cell research will probably end up with a procedure or process as the treatment. The patient will be his or her own donor and the pharmacetuical companies will not have a customer for life from these treatments. More than likely, the treatment will end up being available in most medical facilities and very affordable.
The embryonic stem cell research is going to end up with a drug company or other large corporation owning the rights to the stem cells the patient receives. Currently there is only a handful of corporations owning all of the rights to the available embryonic stem cells and all rights to any future discoveries. The patient will also more than likely be destined to be on anti-rejection meds for the rest of their life.
Follow the money:
Here is Wicell's, which is non-profit shell corporation for the University of Wisconson-Madison, original agreement with the National Institue of Health. Note who retains the commercial rights to the research, the money.
I would be interested in hearing opinions on the ethics of corporations owning the legal rights to someones DNA. This would seem to me to be taking property ownership and a type of slavery to new heights.
The site is probably somewhat biased, however the information is also true.
I see the whole embryonic stem cell issue as a canard. The real issue is MONEY and CONTROL. The adult stem cell research, which does not have the ethical dilemas, has been progressing quite well, though very quietly, in some high profile labs such as MIT and John Hopkins.
All ethical issues aside, the adult stem cell research will probably end up with a procedure or process as the treatment. The patient will be his or her own donor and the pharmacetuical companies will not have a customer for life from these treatments. More than likely, the treatment will end up being available in most medical facilities and very affordable.
The embryonic stem cell research is going to end up with a drug company or other large corporation owning the rights to the stem cells the patient receives. Currently there is only a handful of corporations owning all of the rights to the available embryonic stem cells and all rights to any future discoveries. The patient will also more than likely be destined to be on anti-rejection meds for the rest of their life.
Follow the money:
Here is Wicell's, which is non-profit shell corporation for the University of Wisconson-Madison, original agreement with the National Institue of Health
I would be interested in hearing opinions on the ethics of corporations owning the legal rights to someones DNA. This would seem to me to be taking property ownership and a type of slavery to new heights.
